The closing price of Conmed Corp. (NYSE: CNMD) was $78.71 for the day, down -8.25% from the previous closing price of $85.79. In other words, the price has decreased by -$6.88 from its previous closing price. On the day, 629274 shares were traded. CNMD stock price reached its highest trading level at $85.28 during the session, while it also had its lowest trading level at $78.46.
Ratios:
Our analysis of CNMD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 99.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.79. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.98. In the meantime, Its Debt-to-Equity ratio is 1.19 whereas as Long-Term Debt/Eq ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on February 01, 2024, Reiterated its Buy rating but revised its target price to $129 from $119 previously.
On May 22, 2023, CL King started tracking the stock assigning a Buy rating and target price of $140.
KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on March 27, 2023, while the target price for the stock was maintained at $124.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 04 ’23 when Peters Stanley W III sold 2,300 shares for $109.93 per share. The transaction valued at 252,833 led to the insider holds 63 shares of the business.
Peters Stanley W III sold 1,200 shares of CNMD for $122,874 on Nov 07 ’23. The President AS and AET now owns 63 shares after completing the transaction at $102.39 per share. On Sep 13 ’23, another insider, Peters Stanley W III, who serves as the President AS and AET of the company, sold 2,000 shares for $107.31 each. As a result, the insider received 214,629 and left with 63 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNMD now has a Market Capitalization of 2.42B and an Enterprise Value of 3.37B. As of this moment, Conmed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.59, and their Forward P/E ratio for the next fiscal year is 14.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.95 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 2.71 whereas that against EBITDA is 17.52.
Stock Price History:
Over the past 52 weeks, CNMD has reached a high of $138.47, while it has fallen to a 52-week low of $78.95. The 50-Day Moving Average of the stock is 91.12, while the 200-Day Moving Average is calculated to be 107.15.
Shares Statistics:
CNMD traded an average of 541.27K shares per day over the past three months and 369.04k shares per day over the past ten days. A total of 30.77M shares are outstanding, with a floating share count of 30.54M. Insiders hold about 0.79% of the company’s shares, while institutions hold 117.91% stake in the company. Shares short for CNMD as of Feb 29, 2024 were 3.96M with a Short Ratio of 7.31, compared to 4.8M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 12.85% and a Short% of Float of 17.82%.
Dividends & Splits
With its trailing 12-month dividend rate of 0.80, CNMD has a forward annual dividend rate of 1.00. Against a Trailing Annual Dividend Yield of 0.93%, it implies a Forward Annual Dividend Yield of 1.02%. The stock’s 5-year Average Dividend Yield is 0.79. The current Payout Ratio is 39.15% for CNMD, which recently paid a dividend on Apr 05, 2024 with an ex-dividend date of Mar 14, 2024. Stock splits for the company last occurred on Sep 10, 2001 when the company split stock in a 3:2 ratio.
Earnings Estimates
The firm’s stock currently is rated by 7 analysts. On average, analysts expect EPS of $0.74 for the current quarter, with a high estimate of $0.74 and a low estimate of $0.73, while EPS last year was $0.66. The consensus estimate for the next quarter is $0.99, with high estimates of $1.12 and low estimates of $0.94.
Analysts are recommending an EPS of between $4.36 and $4.3 for the fiscal current year, implying an average EPS of $4.33. EPS for the following year is $5.62, with 8 analysts recommending between $5.8 and $5.37.
Revenue Estimates
A total of 8 analysts have provided revenue estimates for CNMD’s current fiscal year. The highest revenue estimate was $1.36B, while the lowest revenue estimate was $1.34B, resulting in an average revenue estimate of $1.35B. In the same quarter a year ago, actual revenue was $1.24B, up 8.40% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $1.47B in the next fiscal year. The high estimate is $1.48B and the low estimate is $1.44B. The average revenue growth estimate for next year is up 8.60% from the average revenue estimate for this year.
